TherapeuticsMD Inc reports results for the quarter ended in March - Earnings Summary

TherapeuticsMD

17/05/2022 17:19

* TherapeuticsMD Inc  TXMD.OQ  reported a quarterly adjusted
loss
of $5.69​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of
$4.00 per share.
    * Revenue fell 2.7% to $19.33 million from a year ago; 
analysts
expected $17.96 million. 
    * TherapeuticsMD Inc's reported EPS for the quarter was a
loss of
$5.69​.
    * The mean earnings estimate of analysts had fallen by
about 60%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TherapeuticsMD Inc shares had fallen by 83.5% this
quarter and
lost 82.3% so far this year.
    * The company reported a quarterly loss of $49.02 million.
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $63.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 17 at 04:18 p.m.  ​All
figures in US dollars unless otherwise stated